• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部癌症患者急性吞咽困难与治疗耐受性的咽鼓管腺剂量前瞻性评估。

A Prospective Evaluation of Tubarial Gland Doses With Acute Dysphagia and Treatment Tolerance in Head and Neck Cancer Patients.

作者信息

Aral İpek Pınar, Altinisik Inan Gonca, Dadak Binnur, Görtan Fatma Arzu, Tezcan Yılmaz

机构信息

Radiation Oncology, Ankara Yıldırım Beyazıt University, Ankara, TUR.

Radiation Oncology, Ankara Bilkent City Hospital, Ankara, TUR.

出版信息

Cureus. 2024 Mar 20;16(3):e56566. doi: 10.7759/cureus.56566. eCollection 2024 Mar.

DOI:10.7759/cureus.56566
PMID:38646264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11029817/
Abstract

Background This study prospectively analyzed the clinical significance of tubarial glands (TGs) doses in head and neck cancer (HNC) patients. Methods Patients diagnosed with HNC in Ankara Bilkent City Hospital, Turkey were analyzed. TGs volumes and doses were noted. The patients were evaluated in terms of acute dysphagia (AD) and radiation therapy (RT)-associated xerostomia. Results The median volume of the TGs was 3.5(2.1-5.9)cc. No increased standardized uptake values (SUV) were observed in the TGs. There was no significant relationship between TGs values and the third or sixth months of xerostomia after RT. There was a significant relationship between grade ≥2 AD and TGs-D (p0.020); TGs-V(p0.007); TGs-V(p0.009); TGs-V(p0.011); TGs-V(p0.010), TGs-V(p0.045). In terms of the risk of grade ≥2 AD, the cut-off value of the TGs-D was analyzed for 50 Gy, with 75% sensitivity and 73.3% specificity (p 0.020; AUC 0.746; 95% CI 0.561-0.929). Additionally for grade ≥2 AD, the cut-off value of the TGs-Vwas analyzed 78 with 81.3% sensitivity and 80.0% specificity (p 0.011; AUC 0.769; 95% CI 0.591-0.947). Conclusion A significant correlation was found between TGs doses and AD during RT. TGs-Vvalue showed higher significance. In future studies, the clinical significance of TGs can be studied especially on this value. The relationship between TGs doses and xerostomia should be evaluated with a larger series.

摘要

背景 本研究前瞻性分析了头颈部癌(HNC)患者咽鼓管腺(TGs)剂量的临床意义。方法 对土耳其安卡拉比尔肯特市医院诊断为HNC的患者进行分析。记录TGs体积和剂量。对患者进行急性吞咽困难(AD)和放射治疗(RT)相关口干的评估。结果 TGs的中位体积为3.5(2.1 - 5.9)立方厘米。TGs中未观察到标准化摄取值(SUV)增加。TGs值与RT后口干的第三个月或第六个月之间无显著关系。≥2级AD与TGs-D(p = 0.020)、TGs-V(p = 0.007)、TGs-V(p = 0.009)、TGs-V(p = 0.011)、TGs-V(p = 0.010)、TGs-V(p = 0.045)之间存在显著关系。就≥2级AD的风险而言,分析了TGs-D的截断值为50 Gy,敏感性为75%,特异性为73.3%(p = 0.020;AUC = 0.746;95% CI = 0.561 - 0.929)。此外,对于≥2级AD,分析了TGs-V的截断值为78,敏感性为81.3%,特异性为80.0%(p = 0.011;AUC = 0.769;95% CI = 0.591 - 0.947)。结论 发现TGs剂量与RT期间的AD之间存在显著相关性。TGs-V值显示出更高的显著性。在未来的研究中,尤其可以基于该值研究TGs的临床意义。应通过更大样本量评估TGs剂量与口干之间的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52da/11029817/a7ebf2341c25/cureus-0016-00000056566-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52da/11029817/f106da5d7927/cureus-0016-00000056566-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52da/11029817/aed40aed8f1d/cureus-0016-00000056566-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52da/11029817/f4e363178d41/cureus-0016-00000056566-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52da/11029817/a7ebf2341c25/cureus-0016-00000056566-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52da/11029817/f106da5d7927/cureus-0016-00000056566-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52da/11029817/aed40aed8f1d/cureus-0016-00000056566-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52da/11029817/f4e363178d41/cureus-0016-00000056566-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52da/11029817/a7ebf2341c25/cureus-0016-00000056566-i04.jpg

相似文献

1
A Prospective Evaluation of Tubarial Gland Doses With Acute Dysphagia and Treatment Tolerance in Head and Neck Cancer Patients.头颈部癌症患者急性吞咽困难与治疗耐受性的咽鼓管腺剂量前瞻性评估。
Cureus. 2024 Mar 20;16(3):e56566. doi: 10.7759/cureus.56566. eCollection 2024 Mar.
2
The tubarial salivary glands: A potential new organ at risk for radiotherapy.管周唾液腺:放射治疗的一个潜在新危险器官。
Radiother Oncol. 2021 Jan;154:292-298. doi: 10.1016/j.radonc.2020.09.034. Epub 2020 Sep 23.
3
Feasibility of Achieving Dose Constraints for Dysphagia Aspiration-Related Structures and Its Clinical Significance in Intensity-Modulated Radiotherapy Planning of Head and Neck Cancer.头颈部癌调强放射治疗计划中吞咽误吸相关结构实现剂量限制的可行性及其临床意义
Cureus. 2024 Feb 7;16(2):e53769. doi: 10.7759/cureus.53769. eCollection 2024 Feb.
4
Tubarial salivary gland sparing with proton therapy.保留管内唾液腺的质子治疗。
Med Dosim. 2022;47(3):222-226. doi: 10.1016/j.meddos.2022.03.001. Epub 2022 Apr 12.
5
Dosimetric Predictors of Patient-Reported Xerostomia and Dysphagia With Deintensified Chemoradiation Therapy for HPV-Associated Oropharyngeal Squamous Cell Carcinoma.人乳头瘤病毒相关口咽鳞状细胞癌减量化放化疗患者报告的口干症和吞咽困难的剂量学预测因素
Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1022-1027. doi: 10.1016/j.ijrobp.2017.03.034. Epub 2017 Mar 27.
6
Identifying organs at risk for radiation-induced late dysphagia in head and neck cancer patients.识别头颈癌患者中存在放射性迟发性吞咽困难风险的器官。
Clin Transl Radiat Oncol. 2019 Aug 30;19:87-95. doi: 10.1016/j.ctro.2019.08.005. eCollection 2019 Nov.
7
Tubarial gland involvement in IgG4-related diseases.IgG4 相关疾病的管周腺累及。
Acta Otolaryngol. 2022 Jul-Aug;142(7-8):616-619. doi: 10.1080/00016489.2022.2104368. Epub 2022 Aug 8.
8
Parotid gland radiation dose-xerostomia relationships based on actual delivered dose for nasopharyngeal carcinoma.基于鼻咽癌实际照射剂量的腮腺辐射剂量与口干症的关系
J Appl Clin Med Phys. 2018 May;19(3):251-260. doi: 10.1002/acm2.12327. Epub 2018 Apr 17.
9
Prediction of Radiation-Induced Parotid Gland-Related Xerostomia in Patients With Head and Neck Cancer: Regeneration-Weighted Dose.预测头颈部癌症患者放疗后腮腺相关口干症:再生加权剂量。
Int J Radiat Oncol Biol Phys. 2023 Nov 1;117(3):750-762. doi: 10.1016/j.ijrobp.2023.04.034. Epub 2023 May 6.
10
Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.头颈部癌患者术后放疗时腮腺和颌下腺的放射性体积变化:一项纵向研究
Laryngoscope. 2009 Oct;119(10):1966-74. doi: 10.1002/lary.20601.

本文引用的文献

1
Tubarial salivary glands on PSMA ligands based PET imaging and post Lu PSMA therapy scan: reiterating its importance.基于PSMA配体的PET成像和镥-PSMA治疗后扫描中的咽鼓管唾液腺:重申其重要性
Asia Ocean J Nucl Med Biol. 2024;12(1):43-45. doi: 10.22038/AOJNMB.2023.72138.1505.
2
Development of a CT-Based Auto-Segmentation Model for Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography-Delineated Tubarial Glands.基于CT的前列腺特异性膜抗原(PSMA)正电子发射断层扫描描绘的咽鼓管腺自动分割模型的开发。
Cureus. 2022 Nov 3;14(11):e31060. doi: 10.7759/cureus.31060. eCollection 2022 Nov.
3
Hyalinizing Clear Cell Salivary Gland Carcinoma of the Epipharynx: A Minor Salivary/Tubarial Gland Malignancy.
下咽透明细胞硬化性唾液腺癌:一种罕见的唾液腺/咽鼓管腺恶性肿瘤。
Biomed Hub. 2022 Feb 25;7(1):31-35. doi: 10.1159/000521830. eCollection 2022.
4
Further Research Needed to Understand Relationship Between Tubarial Glands and Eustachian Tube Dysfunction.需要进一步研究以了解咽鼓管腺与咽鼓管功能障碍之间的关系。
Otolaryngol Head Neck Surg. 2021 Dec;165(6):759-761. doi: 10.1177/01945998211004256. Epub 2021 Apr 13.
5
Can the function of the tubarial glands be evaluated using [Tc]pertechnetate SPECT/CT, [F]FDG PET/CT, and [C]methionine PET/CT?能否使用高锝[Tc]酸盐单光子发射计算机断层扫描/计算机断层扫描(SPECT/CT)、氟[F]脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(PET/CT)以及碳[C]蛋氨酸PET/CT来评估咽鼓管腺的功能?
EJNMMI Res. 2021 Mar 31;11(1):34. doi: 10.1186/s13550-021-00779-6.
6
Are "tubarial salivary glands" a previously unknown structure?“咽鼓管唾液腺”是一种此前未知的结构吗?
Radiother Oncol. 2021 Jan;154:314-315. doi: 10.1016/j.radonc.2020.12.003. Epub 2020 Dec 11.
7
Comments on "The tubarial salivary glands: First description of a potential new organ at risk for head-neck radiotherapy".关于《咽鼓管唾液腺:头颈部放疗中一个潜在新的危险器官的首次描述》的评论
Radiother Oncol. 2021 Jan;154:316-317. doi: 10.1016/j.radonc.2020.12.004. Epub 2020 Dec 11.
8
The tubarial salivary glands: A potential new organ at risk for radiotherapy.管周唾液腺:放射治疗的一个潜在新危险器官。
Radiother Oncol. 2021 Jan;154:292-298. doi: 10.1016/j.radonc.2020.09.034. Epub 2020 Sep 23.
9
MRI- and CT-determined changes of dysphagia / aspiration-related structures (DARS) during and after radiotherapy.MRI 和 CT 评估放疗过程中和放疗后吞咽/吸入相关结构(DARS)的变化。
PLoS One. 2020 Sep 2;15(9):e0237501. doi: 10.1371/journal.pone.0237501. eCollection 2020.
10
Prostate-Specific Membrane Antigen Expression in Primary Juvenile Nasal Angiofibroma-A Pilot Study.前列腺特异性膜抗原在原发性青少年鼻血管纤维瘤中的表达——一项初步研究。
Clin Nucl Med. 2020 Mar;45(3):195-199. doi: 10.1097/RLU.0000000000002928.